Back    Zoom +    Zoom -
CN NHSA: Negotiations of New Reimbursement Drug List Next Wk in Beijing; Results to be Announced Next Mth
Recommend
24
Positive
45
Negative
19
According to the work arrangements, on-site negotiations/ price bidding for the 2024 Catalogue of National Reimbursement Drug List are scheduled to be held in Beijing from Sunday (27th) to next Wednesday (30th), as CCTV learned from the National Healthcare Security Administration (NHSA).

It is expected that the results of the adjustment will be announced in November, and the new Catalogue will be implemented starting in 2025.

Related NewsCMBI Eyes Opportunities in Innovative Medical Insurance, Prefers WuXi AppTec/ BeiGene/ INNOVENT BIO/ SKB BIO-B/ GIANT BIOGENE/ 3SBIO/ Mindray Bio-Medical
According to the "2024 Adjustment Work Plan for Catalogue of National Reimbursement Drug List", the seventh adjustment of the Catalogue since the establishment of the NHSA was officially launched in July.

After formal review, expert review and result confirmation, a total of 162 generic drugs were confirmed to participate in negotiations/ price bidding.
AAStocks Financial News